Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model-Reference-Cited by-同舟云学术

Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model

Published:2021-05-12 Issue:7 Volume:18 Page:1652-1661
ISSN:1672-7681
Container-title:Cellular & Molecular Immunology
language:en
Short-container-title:Cell Mol Immunol

Author:

Thangaraj Jaya Lakshmi,Ahn Seo-Yeon,Jung Sung-Hoon,Vo Manh-Cuong,Chu Tan-Huy,Thi Phan Minh-Trang,Kwon Minsuk,Lee Kyung-Hwa,Kim Mihee,Song Ga-Young,Yang Deok-Hwan,Ahn Jae-Sook,Kim Hyeoung-Joon,Cho Duck,Lee Je-Jung

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41423-021-00686-9.pdf

Reference48 articles.

1. Roodman, G. D. Pathogenesis of myeloma bone disease. Leukemia 23, 435–441 (2009).

2. Rajkumar, S. V. & Kumar, S. Multiple myeloma: diagnosis and treatment. Mayo Clin. Proc. 91, 101–119 (2016).

3. Al-Hujaily E. M., Oldham R. A., Hari P., Medin J. A. Development of Novel Immunotherapies for Multiple Myeloma. Int. J. Mol. Sci. 17, 1506 https://doi.org/10.3390/ijms17091506 (2016).

4. Berahovich R., et al. CAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell Growth. Cancers (Basel). 10, 323 https://doi.org/10.3390/cancers10090323 (2018).

5. Leung, W. Infusions of allogeneic natural killer cells as cancer therapy. Clin. Cancer Res. 20, 3390–3400 (2014).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daratumumab‑resistant multiple myeloma with extramedullary disease successfully treated with combination elotuzumab, pomalidomide and dexamethasone: A case report;Oncology Letters;2024-04-03

2. Prognostic marker CD27 and its micro-environmental in multiple myeloma;BMC Cancer;2024-03-19

3. Exploring cellular immunotherapy platforms in multiple myeloma;Heliyon;2024-03

4. Natural killer cells affect the natural course, drug resistance, and prognosis of multiple myeloma;Frontiers in Cell and Developmental Biology;2024-02-12

5. Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma;Journal for ImmunoTherapy of Cancer;2024-01